Molecular Diagnostics

Plasma Lipidome Investigated in Hereditary Hemochromatosis
Hereditary hemochromatosis (HH) is an autosomal recessive genetic disorder with increased intestinal iron absorption which leads to iron overload and consequently to tissue damage and functional impairment of organs like liver, pancreas, and heart. More...28 Jul 2020

Circulating Tumor DNA Associated with Triple-Negative Breast Cancer Recurrence
Patients with early-stage triple-negative breast cancer (TNBC) are frequently treated with neoadjuvant chemotherapy, based on the increased risk for recurrence and death associated with this category of tumors. More...27 Jul 2020

CtDNA Assay for Cancer Recurrence, MRD Applications Demonstrated
Circulating tumor DNA (ctDNA) is found in the bloodstream and refers to DNA that comes from cancerous cells and tumors. Most DNA is inside a cell's nucleus. As a tumor grows, cells die and are replaced by new ones. The dead cells get broken down and their contents, including DNA, are released into the bloodstream. More...22 Jul 2020
![Image: A scanning electron microscope image of normal circulating human blood showing red blood cells, several types of white blood cells including lymphocytes, a monocyte, a neutrophil and many small disc-shaped platelets (Photo courtesy of [U.S.] National Cancer Institute) Image: A scanning electron microscope image of normal circulating human blood showing red blood cells, several types of white blood cells including lymphocytes, a monocyte, a neutrophil and many small disc-shaped platelets (Photo courtesy of [U.S.] National Cancer Institute)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2020-07-22/GMS-087B.jpg)


Immunogenomic Landscape of Hematological Malignancies Mapped
The reaction of the body's immune system against cancer can be thought of as a cycle. Cancer cells contain proteins that differ from proteins in other tissue. Their components, known as antigens, have to be presented to the T cells of the immune system by the cancer cells. More...20 Jul 2020

In Other News
Clonal Hematopoiesis of Indeterminate Potential Associated with hsC-Reactive Protein
Combined DNA/RNA Liquid Biopsy Test Identifies Genetic Aberrations in Metastatic Prostate Cancer
Gene Genomic Prostate Score Test Evaluated as Prognosis Predictor
Early-Onset Preeclampsia Risk Reflected in Circulating Maternal Transcripts
Rapid Genomic Profiling of Colon Cancers Improves Therapy Selection
Gut Microbiome Metabolomic Profiles Are Diagnostic for Liver Diseases
DNA Sequencing Technique Unravels Genetic Diversity of Cancer Tumors
An Eight MicroRNA Biomarker Panel for Diagnosis of ALS
RNA Sequencing as Alternative to Immunohistochemistry in Cancer Diagnostics
Blood Group Locus Contributes to COVID-19 Severity Risk
Precision Medicine-Based Genetic Testing Developed for Prostate Cancer
Sensitive and Accurate Cancer Detection Through Analysis of Circulating Free DNA Methylation Patterns
Highly Sensitive Liquid Biopsy Technique Brings Personalized Cancer Monitoring a Step Closer
Gut Microbiome Dysbiosis Characterized in Parkinson’s Disease
Serum Mir‐22 Prognostic Marker Explored for Acute Myeloid Leukemia
Isothermal Amplification Method Used to Detect Salmonella Subtypes
Serum Neurofilament Light Chain Is a Potential Prognostic Biomarker for Frontotemporal Lobar Degeneration
Diagnosing Liver Cancer by Screening Viral Exposure History
A Novel Liquid Biopsy Device Enables Early Cancer Detection and Diagnosis
Blood Test Predicts Prostate Cancer Treatment Response
A Simple Paper-Based, Wearable Device for Long Term Sweat Analysis
Sensitive Separation Device Enables Diagnostic Analysis of Cancer Exosomes
Tumor Mutation and Immune Microenvironment Revealed in Colorectal Cancer
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.







